Phase I/II Study of ASP9521 in Castrate-Resistant Prostate Cancer (CRPC) Patients

NCT01352208 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
13
Enrollment
INDUSTRY
Sponsor class

Stopped It was decided to discontinue the development in consideration of the results of a P1 study

Conditions

Interventions

Sponsor

Astellas Pharma Inc